Atlas Trials

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

Clinical trial NCT02512926 · COMPLETED

Trial details

NCT number
NCT02512926
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed Solid TumorsRefractory Solid TumorsRelapsed LeukemiaRefractory Leukemia
Start date
2016-02-16
Primary completion
2021-08-28
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.